Chestnut Hill, MA, United States of America

Toshimichi Shinohara

This inventor holds 1 USPTO granted patent. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshimichi Shinohara. Retrieved from https://idiyas.com/inventor/toshimichi-shinohara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Toshimichi Shinohara: Innovator in Lens Epithelial Cell Derived Growth Factor

Introduction

Toshimichi Shinohara is a notable inventor based in Chestnut Hill, MA (US). He has made significant contributions to the field of biomedical research, particularly in the area of growth factors.

Latest Patents

Shinohara holds a patent for a lens epithelial cell derived growth factor. This invention pertains to nucleic acids encoding a lens epithelial cell derived growth factor protein, including fragments and biologically functional variants thereof. The invention also encompasses therapeutics and diagnostics involving these proteins and genes, as well as agents that bind to them. He has 1 patent to his name.

Career Highlights

Toshimichi Shinohara is affiliated with Brigham and Women's Hospital, Inc., where he continues to advance research in his field. His work has implications for therapeutic applications and understanding cellular mechanisms.

Collaborations

Shinohara has collaborated with esteemed colleagues such as Dhirendra Singh and Leo T Chylack, Jr. Their combined expertise enhances the impact of their research endeavors.

Conclusion

Toshimichi Shinohara's innovative work in lens epithelial cell derived growth factor exemplifies the importance of research in advancing medical science. His contributions are paving the way for future developments in therapeutics and diagnostics.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…